Literature DB >> 32483556

HIV LATENT RESERVOIR CURE STRATEGIES.

Christopher J Destache1.   

Abstract

Entities:  

Year:  2016        PMID： 32483556      PMCID： PMC7262689          DOI： 10.22580/2016/iscinotej1.1.2

Source DB:  PubMed          Journal:  Isci Notes        ISSN： 2456-9577


× No keyword cloud information.
  10 in total

Review 1.  CCR5Δ32 mutation and HIV infection: basis for curative HIV therapy.

Authors:  Kristina Allers; Thomas Schneider
Journal:  Curr Opin Virol       Date:  2015-07-01       Impact factor: 7.090

Review 2.  Progress and challenges in the use of latent HIV-1 reactivating agents.

Authors:  Hong-tao Shang; Ji-wei Ding; Shu-ying Yu; Tao Wu; Qiu-li Zhang; Fu-jun Liang
Journal:  Acta Pharmacol Sin       Date:  2015-06-01       Impact factor: 6.150

Review 3.  The role of IL-10 in regulating immunity to persistent viral infections.

Authors:  Elizabeth B Wilson; David G Brooks
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

4.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.

Authors:  Cheryl L Day; Daniel E Kaufmann; Photini Kiepiela; Julia A Brown; Eshia S Moodley; Sharon Reddy; Elizabeth W Mackey; Joseph D Miller; Alasdair J Leslie; Chantal DePierres; Zenele Mncube; Jaikumar Duraiswamy; Baogong Zhu; Quentin Eichbaum; Marcus Altfeld; E John Wherry; Hoosen M Coovadia; Philip J R Goulder; Paul Klenerman; Rafi Ahmed; Gordon J Freeman; Bruce D Walker
Journal:  Nature       Date:  2006-08-20       Impact factor: 49.962

Review 5.  Manipulating IL-10 signalling blockade for better immunotherapy.

Authors:  Guoying Ni; Tianfang Wang; Shelley Walton; Bin Zhu; Shu Chen; Xiaolian Wu; Yuejian Wang; Ming Q Wei; Xiaosong Liu
Journal:  Cell Immunol       Date:  2015-01-08       Impact factor: 4.868

Review 6.  Histone deacetylase inhibitors merged with protein tyrosine kinase inhibitors.

Authors:  Nan Zhou; Wenfang Xu; Yingjie Zhang
Journal:  Drug Discov Ther       Date:  2015-06

7.  Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.

Authors:  Julie R Brahmer; Scott S Tykodi; Laura Q M Chow; Wen-Jen Hwu; Suzanne L Topalian; Patrick Hwu; Charles G Drake; Luis H Camacho; John Kauh; Kunle Odunsi; Henry C Pitot; Omid Hamid; Shailender Bhatia; Renato Martins; Keith Eaton; Shuming Chen; Theresa M Salay; Suresh Alaparthy; Joseph F Grosso; Alan J Korman; Susan M Parker; Shruti Agrawal; Stacie M Goldberg; Drew M Pardoll; Ashok Gupta; Jon M Wigginton
Journal:  N Engl J Med       Date:  2012-06-02       Impact factor: 91.245

Review 8.  CAR T-cells merge into the fast lane of cancer care.

Authors:  Noelle V Frey; David L Porter
Journal:  Am J Hematol       Date:  2016-01       Impact factor: 10.047

Review 9.  Targeting the latent reservoir to achieve functional HIV cure.

Authors:  Daniele C Cary; B Matija Peterlin
Journal:  F1000Res       Date:  2016-05-26

Review 10.  CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape.

Authors:  Gero Hütter; Josef Bodor; Scott Ledger; Maureen Boyd; Michelle Millington; Marlene Tsie; Geoff Symonds
Journal:  Viruses       Date:  2015-07-27       Impact factor: 5.048
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.